1
|
Kinsey CM, Billatos E, Mori V, Tonelli B, Cole BF, Duan F, Marques H, de la Bruere I, Onieva J, San José Estépar R, Cleveland A, Idelkope D, Stevenson C, Bates JHT, Aberle D, Spira A, Washko G, San José Estépar R. A simple assessment of lung nodule location for reduction in unnecessary invasive procedures. J Thorac Dis 2021; 13:4207-4216. [PMID: 34422349 PMCID: PMC8339782 DOI: 10.21037/jtd-20-3093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Accepted: 04/23/2021] [Indexed: 12/05/2022]
Abstract
Background CT screening for lung cancer results in a significant mortality reduction but is complicated by invasive procedures performed for evaluation of the many detected benign nodules. The purpose of this study was to evaluate measures of nodule location within the lung as predictors of malignancy. Methods We analyzed images and data from 3,483 participants in the National Lung Screening Trial (NLST). All nodules (4–20 mm) were characterized by 3D geospatial location using a Cartesian coordinate system and evaluated in logistic regression analysis. Model development and probability cutpoint selection was performed in the NLST testing set. The Geospatial test was then validated in the NLST testing set, and subsequently replicated in a new cohort of 147 participants from The Detection of Early Lung Cancer Among Military Personnel (DECAMP) Consortium. Results The Geospatial Test, consisting of the superior-inferior distance (Z distance), nodule diameter, and radial distance (carina to nodule) performed well in both the NLST validation set (AUC 0.85) and the DECAMP replication cohort (AUC 0.75). A negative Geospatial Test resulted in a less than 2% risk of cancer across all nodule diameters. The Geospatial Test correctly reclassified 19.7% of indeterminate nodules with a diameter over 6mm as benign, while only incorrectly classifying 1% of cancerous nodules as benign. In contrast, the parsimonious Brock Model applied to the same group of nodules correctly reclassified 64.5% of indeterminate nodules as benign but resulted in misclassification of a cancer as benign in 18.2% of the cases. Applying the Geospatial test would result in reducing invasive procedures performed for benign lesions by 11.3% with a low rate of misclassification (1.3%). In contrast, the Brock model applied to the same group of patients results in decreasing invasive procedures for benign lesion by 39.0% but misclassifying 21.1% of cancers as benign. Conclusions Utilizing information about geospatial location within the lung improves risk assessment for indeterminate lung nodules and may reduce unnecessary procedures. Trial Registration NCT00047385, NCT01785342.
Collapse
Affiliation(s)
- C Matthew Kinsey
- Division of Pulmonary and Critical Care, University of Vermont Medical Center, Burlington, VT, USA
| | - Ehab Billatos
- Section of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University, Boston, MA, Boston Medical Center, Boston, MA, USA
| | - Vitor Mori
- University of Sao Paolo, Sao Paolo, Brazil
| | | | - Bernard F Cole
- Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA
| | - Fenghai Duan
- Department of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA
| | - Helga Marques
- Center for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA
| | | | - Jorge Onieva
- Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA
| | | | | | - Dan Idelkope
- Geisel School of Medicine at Dartmouth College, Hanover, NH, USA
| | | | - Jason H T Bates
- Division of Pulmonary and Critical Care, University of Vermont Medical Center, Burlington, VT, USA
| | - Denise Aberle
- David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
| | - Avi Spira
- The Pulmonary Unit, Boston Medical Center, Boston, MA, USA
| | - George Washko
- Division of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, USA
| | | |
Collapse
|